A detailed history of Byrne Financial Freedom, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Byrne Financial Freedom, LLC holds 453 shares of LLY stock, worth $400,995. This represents 0.21% of its overall portfolio holdings.

Number of Shares
453
Previous 453 -0.0%
Holding current value
$400,995
Previous $350 Million 7.02%
% of portfolio
0.21%
Previous 0.16%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Apr 29, 2025

BUY
$727.2 - $932.06 $329,421 - $422,223
453 New
453 $350 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $841B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Byrne Financial Freedom, LLC Portfolio

Follow Byrne Financial Freedom, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Byrne Financial Freedom, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Byrne Financial Freedom, LLC with notifications on news.